Cargando…
Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. CASE PRESENTATION: We describe a 78-year old immunocompromis...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301053/ https://www.ncbi.nlm.nih.gov/pubmed/32552792 http://dx.doi.org/10.1186/s12883-020-01812-2 |
_version_ | 1783547613133406208 |
---|---|
author | Farhadian, Shelli Glick, Laura R. Vogels, Chantal B. F. Thomas, Jared Chiarella, Jennifer Casanovas-Massana, Arnau Zhou, Jing Odio, Camila Vijayakumar, Pavithra Geng, Bertie Fournier, John Bermejo, Santos Fauver, Joseph R. Alpert, Tara Wyllie, Anne L. Turcotte, Cynthia Steinle, Matthew Paczkowski, Patrick Dela Cruz, Charles Wilen, Craig Ko, Albert I. MacKay, Sean Grubaugh, Nathan D. Spudich, Serena Barakat, Lydia Aoun |
author_facet | Farhadian, Shelli Glick, Laura R. Vogels, Chantal B. F. Thomas, Jared Chiarella, Jennifer Casanovas-Massana, Arnau Zhou, Jing Odio, Camila Vijayakumar, Pavithra Geng, Bertie Fournier, John Bermejo, Santos Fauver, Joseph R. Alpert, Tara Wyllie, Anne L. Turcotte, Cynthia Steinle, Matthew Paczkowski, Patrick Dela Cruz, Charles Wilen, Craig Ko, Albert I. MacKay, Sean Grubaugh, Nathan D. Spudich, Serena Barakat, Lydia Aoun |
author_sort | Farhadian, Shelli |
collection | PubMed |
description | BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. CASE PRESENTATION: We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion. CONCLUSION: Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease. |
format | Online Article Text |
id | pubmed-7301053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-73010532020-06-18 Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 Farhadian, Shelli Glick, Laura R. Vogels, Chantal B. F. Thomas, Jared Chiarella, Jennifer Casanovas-Massana, Arnau Zhou, Jing Odio, Camila Vijayakumar, Pavithra Geng, Bertie Fournier, John Bermejo, Santos Fauver, Joseph R. Alpert, Tara Wyllie, Anne L. Turcotte, Cynthia Steinle, Matthew Paczkowski, Patrick Dela Cruz, Charles Wilen, Craig Ko, Albert I. MacKay, Sean Grubaugh, Nathan D. Spudich, Serena Barakat, Lydia Aoun BMC Neurol Case Report BACKGROUND: COVID-19 is caused by the severe acute respiratory syndrome virus SARS-CoV-2. It is widely recognized as a respiratory pathogen, but neurologic complications can be the presenting manifestation in a subset of infected patients. CASE PRESENTATION: We describe a 78-year old immunocompromised woman who presented with altered mental status after witnessed seizure-like activity at home. She was found to have SARS-CoV-2 infection and associated neuroinflammation. In this case, we undertake the first detailed analysis of cerebrospinal fluid (CSF) cytokines during COVID-19 infection and find a unique pattern of inflammation in CSF, but no evidence of viral neuroinvasion. CONCLUSION: Our findings suggest that neurologic symptoms such as encephalopathy and seizures may be the initial presentation of COVID-19. Central nervous system inflammation may associate with neurologic manifestations of disease. BioMed Central 2020-06-18 /pmc/articles/PMC7301053/ /pubmed/32552792 http://dx.doi.org/10.1186/s12883-020-01812-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Farhadian, Shelli Glick, Laura R. Vogels, Chantal B. F. Thomas, Jared Chiarella, Jennifer Casanovas-Massana, Arnau Zhou, Jing Odio, Camila Vijayakumar, Pavithra Geng, Bertie Fournier, John Bermejo, Santos Fauver, Joseph R. Alpert, Tara Wyllie, Anne L. Turcotte, Cynthia Steinle, Matthew Paczkowski, Patrick Dela Cruz, Charles Wilen, Craig Ko, Albert I. MacKay, Sean Grubaugh, Nathan D. Spudich, Serena Barakat, Lydia Aoun Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 |
title | Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 |
title_full | Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 |
title_fullStr | Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 |
title_full_unstemmed | Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 |
title_short | Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19 |
title_sort | acute encephalopathy with elevated csf inflammatory markers as the initial presentation of covid-19 |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301053/ https://www.ncbi.nlm.nih.gov/pubmed/32552792 http://dx.doi.org/10.1186/s12883-020-01812-2 |
work_keys_str_mv | AT farhadianshelli acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT glicklaurar acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT vogelschantalbf acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT thomasjared acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT chiarellajennifer acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT casanovasmassanaarnau acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT zhoujing acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT odiocamila acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT vijayakumarpavithra acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT gengbertie acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT fournierjohn acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT bermejosantos acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT fauverjosephr acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT alperttara acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT wyllieannel acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT turcottecynthia acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT steinlematthew acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT paczkowskipatrick acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT delacruzcharles acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT wilencraig acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT koalberti acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT mackaysean acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT grubaughnathand acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT spudichserena acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 AT barakatlydiaaoun acuteencephalopathywithelevatedcsfinflammatorymarkersastheinitialpresentationofcovid19 |